Board changes at Phase2Therapy

  • October 30, 2017
  • Team

Phase2Therapy announces changes in the board. Joop van Lunteren will step down as a board member. His replacement will be Dimor Elbers, Associate Director at Lonza. We would like to express our gratitute for Joop’s invaluable contribution to Phase2Therapy and…

Read More
New Publication: The Chimeric Investigator

New publication: The Chimeric Investigator

Recently Huib Vriesendorp and Hal Drooglever Fortuyn issued a new publication, titled: The Chimeric Investigator, an Endangered Species. A Chimeric Investigator has both an MD ‘genotype’ and an Investigator ‘genotype’: a good starting point for translating serious problems of patients…

Read More
ISEH Annual Scientific Meeting

ISEH Annual Scientific Meeting

From August 25 to 28, the International Society of Experimental Hematology organized its 45th Annual Scientific Meeting. The event was held in San Diego, U.S.A. On behalf of Phase2Therapy, Huib Vriesendorp joined the conference.

Read More
P2T Publication Graft Versus Host Disease

P2T publication Graft versus Host Disease

Phase2Therapy is happy to announce that ‘History of Graft versus Host Disease' written by P2T Board members  Huib Vriesendorp and Peter Heidt has been accepted for publication in the Journal of Experimental Hematology. The publication provides a biosketch of the…

Read More
2015 Paris Assembly

2015 Paris Assembly

In April P2T attended the Paris Assembly of Sage Bionetworks at the Institut Pasteur. With as theme: 'Connecting Open Research, Open Education and Open Social Impact.' It formed an excellent opportunity to introduce Phase2Therapy.

Read More
Dick Van Bekkum

Dick van Bekkum

  • August 27, 2015
  • Team

The unforgettable Dick van Bekkum passed away at almost 90 years of age. His energy, friendship, advice, humor and tutoring will continue to inspire P2T and all its current and future projects.

Read More
Search